Selected article for: "antiviral therapy and tract infection"

Author: Im, Kyungtaek; Kim, Jisu; Min, Hyeyoung
Title: Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection
  • Document date: 2015_9_16
  • ID: u800148j_6
    Snippet: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection. This viral infection shows mild and indistinguishable symptoms from common colds in adults and healthy children but can also cause severe lower respiratory tract diseases such as pneumonia and bronchiolitis in premature babies and infants with underlying health conditions and immunocompromised patients. No effective antiviral therapy or preventive vaccine.....
    Document: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection. This viral infection shows mild and indistinguishable symptoms from common colds in adults and healthy children but can also cause severe lower respiratory tract diseases such as pneumonia and bronchiolitis in premature babies and infants with underlying health conditions and immunocompromised patients. No effective antiviral therapy or preventive vaccine in early life is currently available, but maternal vaccination is considered a possible strategy to provide RSV antibody protection to young infants [1] .

    Search related documents:
    Co phrase search for related documents
    • antibody protection and early life: 1, 2, 3
    • antibody protection and maternal vaccination: 1, 2, 3
    • antibody protection and possible strategy: 1
    • antibody protection and respiratory syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antibody protection and respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • antibody protection and respiratory tract disease: 1
    • antibody protection and respiratory tract infection: 1, 2, 3, 4, 5, 6
    • antibody protection and rsv antibody protection: 1, 2, 3, 4, 5
    • antibody protection and rsv antibody protection provide: 1, 2
    • antibody protection and RSV respiratory syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antibody protection and syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antibody protection and tract infection: 1, 2, 3, 4, 5, 6, 7, 8
    • antibody protection and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • antibody protection and young infant: 1, 2
    • antiviral therapy and common cold: 1, 2, 3, 4
    • antiviral therapy and early life: 1, 2
    • antiviral therapy and effective antiviral therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • antiviral therapy and health condition: 1
    • antiviral therapy and lead cause: 1